afm13
Showing 1 - 3 of 3
Relapsed or Refractory Hodgkin Lymphoma, Peripheral T Cell Lymphoma Trial (AFM13, AB-101, Cyclophosphamide)
Not yet recruiting
- Relapsed or Refractory Hodgkin Lymphoma
- Peripheral T Cell Lymphoma
- AFM13
- +4 more
- (no location specified)
May 30, 2023
Hodgkin Lymphoma Trial in Cologne (AFM13)
Completed
- Hodgkin Lymphoma
- AFM13
-
Cologne, Germany1st Department of Medicine, Cologne University Hospital
Nov 11, 2020
Lymphoma, T-Cell, Cutaneous Trial in New York (AFM13)
Completed
- Lymphoma, T-Cell, Cutaneous
- AFM13
-
New York, New YorkCenter for Lymphoid Malignancies
Jul 14, 2020